Corporate Governance

Per-Anders Johansson has extensive experience from technology and development companies and is an active investor through CIMON AB. CIMON AB has invested in and developed several
successful companies. Per-Anders Johansson also has long industrial experience from the Karlshamns group, Nordico and Ellos where he
has held leading positions.

Qualifications
Mechanical engineer, specialised in process technology.

Shareholding
35,000 shares privately, 941,809 shares through CIMON Venture Trust AB and 310,000 shares through NOMIC AB.

Dependence
Yes. Dependence in relation to CIMON Venture Trust AB, independent of company.

Glenn Paxman is the founder of Paxman and responsible for the design and development of the scalp cooler. He has over 40 years of business experience including management strategy and product design of med-tech products, and over 25 years of experience in developing manufacturing processes for the pharmaceutical and
chemical industry sectors. Glenn is also the founder and chairman of Brewfitt Ltd. Currently, his role in the company is to support
the board and management in strategic matters and assist in growth-stimulating projects on the American market.

Qualifications
Mechanical engineer in process technology, specialised in manufacturing technology.

Shareholding
2,566,386 shares

Dependence
Yes, in his capacity as a major shareholder.

Björn Littorin has
extensive experience as a
management consultant,
business leader and board member of both manufacturing and service-based companies as well as 20 years’ experience as Investment Manager and board member of technology and development companies, mostly within medical technology. Some of the companies where he has been CEO or board member have been listed on the Stockholm Stock Exchange. He has also been
a board member of Paxman Group Ltd and its subsidiary Paxman Coolers Ltd since 2001.

Qualifications
MSc in Engineering from Chalmers University of Technology.

Shareholding
347,865 shares

Dependence
Independent in relation to the company and its management as well as major shareholders.

Born 1961, Robert Kelly is an attorney specialised in corporate law but is also an authorised public accountant. Robert Kelly has extensive experience of business management in both private and public companies such as Minorplanet Systems plc, Caudwell Group and Kunick plc. Up to 2016, Robert Kelly was Managing Partner of Armitage Sykes Solicitors Limited. He managed the sale of Armitage Sykes to Schofield Sweeney LLP, where he remained a corporate partner for 7 years before joining Holden Smith Law. He is a member of the audit committee of the University of Huddersfield.

Qualifications
M.A. from Oxford University, Graduate Diploma in Law from University of Huddersfield, Legal Practice Course from College of Law in York.

Shareholding
33,212 shares

Dependence
Independent in relation to the company and its management as well as major shareholders.

Maria Bech has extensive experience from several companies in the biotech and pharmaceutical sector. She has held leading positions, including Clinical Project Manager and Study Delivery Director at AstraZeneca, Director Clinical Operations and Principal Project Manager at Karo Bio AB, and Chief Scientific Officer at Smartfish AB. Maria is a board member of Neuronano AB and Hoseth Biocare AS, and CEO of EpiEndo Pharmaceuticals.

Qualifications
Master of Science in molecular biology.

Shareholding
8,700 shares

Dependence
Independent in relation to the company and its management as well as major shareholders.

Born in 1967, Mats has extensive experience from several companies as an equity analyst, strategist, fund manager and finance journalist. He has covered many sectors as an equity analyst and has been exposed to the challenges posed by listed companies from many angles including investor relations and reporting issues as well as communication strategies and financial markets. Mats has worked with several reputable equity research companies, as well as working as a financial journalist for Affärsvärlden.

Qualifications
Bachelor of Science in Business Administration and an MBA in Finance from the International University of Monaco. Certificate of Hotel Management from IHTTI, Switzerland, as well as French from the Sorbonne.

Shareholding
7,600 shares

Dependence
Independence in relation to the company and its management as well as major shareholders.

Employed at Paxman since 2009, Richard Paxman has extensive experience in global market development including clinical trial design and regulatory approvals specifically related to scalp cooling. Richard Paxman has been active within the business since 2007, and has also held a management role for Brewfitt Ltd prior to his engagement in Paxman. Richard Paxman is a board member of Brewfitt Ltd and all companies within the Paxman Group.

Awarded the OBE for services to international trade in the King’s first Birthday Honours List in June 2023, Richard is passionate about international trade and promoting the UK overseas.

Richard is also a private sector member of the Business Economy Innovation Committee (BEIC) for the West Yorkshire Combined Authority (WYCA) as well as Chair of the WYCA HealthTech Cluster. He participates as a Medilink North of England Advisory Group Member.

Qualifications
Management Science at University of Manchester, Institute of Science and Technology.

Shareholding
1,222,880 shares

Dependence
Yes, due to his position as an employee and significant shareholder of the Company.

Born in 1960, Karen has over 35 years of experience as a senior sales executive and turnaround leader, with experience working in sales strategy, customer experience, marketing, product management and organisational development. Karen serves as VP of Sales for EasyVote Solutions. Previously, Karen held the position of Executive Director of Market Development at Hart InterCivic, Vice President of North American Sales at Everyone Counts, and managed a portfolio of over $170 million at DST Systems.

Qualifications
BA in Public Administration from San Diego State University, Certificate of Marketing Communications from University of California, Los Angeles.

Shareholding
25,256 shares

Dependence
Independent in relation to the company and its management as well as major shareholders.

Employed at Paxman since 2009, Richard Paxman has extensive experience in global market development including clinical trial design and regulatory approvals specifically related to scalp cooling. Richard Paxman has been active within the business since 2007, and has also held a management role for Brewfitt Ltd prior to his engagement with Paxman. Richard Paxman is a board member of Brewfitt Ltd and all companies within the Paxman Group.

Awarded the OBE for services to international trade in the King’s first Birthday Honours List in June 2023, Richard is passionate about international trade and promoting the UK overseas.

Richard is also a private sector member of the Business Economy Innovation Committee (BEIC) for the West Yorkshire Combined Authority (WYCA) as well as Chair of the WYCA HealthTech Cluster. He participates as a Medilink North of England Advisory Group Member.

Qualifications
Management Science at University of Manchester, Institute of Science and Technology.

Shareholding
1,222,880 shares

Employed at Paxman since 1 March 2020, Emelie Gustafsson has been the CFO of the entire CIMON Group since 2015 and is a Board member of a large number of companies within this Group. She is also the Investor Relations manager in Skolon AB (publ)

Qualifications
University studies in business administration and tax law (University of Kristianstad).

Shareholding
4,140 shares

Claire has progressed through a number of roles within the company since joining in 2010, initially providing training for UK hospitals before utilising her business development and sales experience to drive major UK market growth – from 35% market share to 98%. This success led to her joining the management team in 2012 and later becoming Director of Sales and Training. Her work advancing clinical training and supporting service expansion evolved into a global training remit, culminating in her joining the Senior Leadership Team in 2019.

As Director of Clinical Practice and Education, Claire provides strategic oversight of Paxman’s global clinical education framework. She works closely with R&D and Regulatory teams on the development, launch, and operational instructions of new products and technologies, ensuring clinical standards are embedded from concept to implementation. She also leads the development of international training and certification programmes.
Claire collaborates with healthcare institutions, advocacy groups, and professional bodies to advance education, awareness, and standardisation in chemotherapy side effect management, strengthening Paxman’s clinical strategy and supporting improved patient outcomes.

Qualifications
Huddersfield Technical College

Shareholding
20,000 shares

Number of warrants held
20,000

Employed at Paxman and a member of management since 2017, Karin Buck is one of the first US employees and brought exceptional experience in marketing, customer service and growing brands when joining the company. Day to day duties include managing the growing US team, building relationships with the Doctors, Nurses and all the Healthcare Providers at hospitals and medical offices and increasing the awareness of scalp cooling in the US by engaging with advocacy groups as well as advertising and marketing programs. Karin has been pivotal in the implementation and adoption of the company’s Insurance-Based Billing Model, driving utilisation and business growth.

Qualifications
Temple University, Journalism.

Shareholding
0 shares

Number of warrants held
0

Employed at Paxman since 2009, Patrick has been a member of management since 2015 and joined the senior leadership team in 2019. Patrick has fulfilled many roles within the company including regulatory, operations and currently R&D, which he oversees. Patrick brings vast industry experience to the company and is a key mentor within the business.

Qualifications
Ordinary National Electrical Engineering, Higher National in Electronics and Computing, BEd Design, and BSc (Hons) Applied Mathematics.

Shareholding
0 shares

Number of warrants held
20,000

Employed at Paxman and a member of management since 2017, Emma Thornhill’s key responsibilities include managing the finance department, finance activities of all trading entities for the group, and preparing all financial reporting, budgeting, and planning. Emma is also responsible for all audit and compliance of the financial statements. Emma works closely with the company CFO in preparation of quarterly and annual reports, and is also a board director for Paxman Group Limited, Paxman Coolers Limited, Paxman US Inc, Paxman Canada Inc, Dignitana US and Dignitana SRL. Emma historically worked in practice at a top 10 UK accountancy firm for 10 years.

Qualifications
FCA Qualified Accountant, BA (Hons) Accounting.

Shareholding
2,186 shares

Number of warrants held
20,000

Employed at Paxman and a member of management since 2024, Louise is an accomplished and versatile marketing professional, with a proven record of developing and executing impactful marketing strategies and meaningful content to meet commercial targets within the med-tech and healthcare industry. She has experience in operating at global level, within EMEA and regionally for the UK, for large multinationals, SMEs and start-up organisations.

Louise’s key responsibilities include the development and management of the Paxman marketing and communication strategy, generating and executing engaging omni-channel campaigns, shaping and elevating the Paxman brand to ensure a positive patient experience, delivering external and internal communications, and leading the Paxman Marketing team.

Qualifications
BA (Hons) Business & Marketing at Manchester Metropolitan University.

Shareholding
0 shares

Number of warrants held
10,000

Alexandra has been with Paxman since 2009 and was appointed to the management team in 2016. Her time at Paxman has seen her lead in roles across the organisation, including regulatory. In her role as Head of Operations, Alexandra is responsible for the development and execution of the group’s operational strategy, supporting the delivery of Paxman’s global growth objectives. Her responsibilities include oversight of production, purchasing, supply chain management and servicing operations, ensuring that operational processes are efficient, scalable and aligned with the group’s strategic priorities. Alexandra works closely with cross-functional teams to drive operational excellence and support the consistent delivery of high-quality products and services to customers worldwide.

Qualifications
Level 2 and 3, Business Administration.

Shareholding
0 shares

Number of warrants held
20,000

Employed at Paxman since 2015, Stuart has been a member of management since 2018. His responsibilities include the management of UK and Ireland training specialists and overseeing all UK and Ireland sales. Wider duties include account management of all UK private healthcare providers” and “our home healthcare provision.

Qualifications
NVQ2- Sport, Recreation and Allied Occupations- Sports Leadership Advanced BTEC National Diploma – Sport and Leisure Studies and ILM Level 7.

Shareholding
367 shares

Number of warrants held
20,000

Employed at Paxman since 1994, Liza joined the management team in 2019. Her key responsibilities include direct liaison with the CEO  on all business activities, including contracting, logistics, travel, diary management and scheduling. Her responsibilities also include close working relationships with the Head of Finance and VP of US. Her position also includes HR function, including contract preparation, onboarding, and liaison with HR/Employment Law consultants.

Qualifications
North of England Higher Secretarial College Diploma.

Shareholding
9,393 shares

Number of warrants held
20,000

Anna began her career in international business development roles within the healthcare sector, supporting organisations in expanding their global reach. She joined Paxman in 2017 and became part of the management team in 2019. Anna’s focus is to continue the mobilisation of Paxman’s global network of distributors and the development of tailored market-entry strategies to improve the accessibility of scalp cooling worldwide. Anna leads the international team based in the UK and overseas staff deployed in India, Scandinavia, France, Spain, and Germany.

Qualifications
International Business Management (MSc), English Studies (MA), Marketing Management (BSc).

Shareholding
0 shares

Number of warrants held
20,000

Employed at Paxman since 2025, Martin ensures compliance with global regulatory requirements, including MDR and MDSAP, and ensures that the requirements of the quality management system and technical files have been effectively defined, documented, implemented, and maintained. He is responsible for all new and existing product registrations worldwide and additionally supports clinical trials where applicable. Prior to Paxman, Martin had 18 years’ experience in the medical device sector, including R&D, Clinical, and Regulatory.

Qualifications
MEng Mechanical Engineering – Durham University
PhD Bioengineering – Durham University
CEng Chartered Engineer – Institution of Mechanical Engineers
PGCert Professional Innovation Management – University of Leeds

Shareholding
0 shares

Number of warrants held
0